Verapamil Dosage for Rate Control

Intravenous Verapamil Dosing

• The American Heart Association recommends an initial dose of 2.5-5 mg IV bolus over 2 minutes for rate control in atrial fibrillation, with repeated doses of 5-10 mg every 15-30 minutes if needed, to a maximum total dose of 20-30 mg 1, 2, 3
• The American College of Cardiology suggests an alternative regimen of 5 mg bolus every 15 minutes to a total dose of 30 mg 1

Oral Verapamil Dosing for Long-term Rate Control

• The European Society of Cardiology recommends standard dosing of 40-120 mg three times daily for long-term rate control 4, 5
• The European Society of Cardiology also recommends extended/sustained-release formulation of 120-480 mg once daily 4, 5
• The American Heart Association suggests a typical maintenance dose range of 120-360 mg daily in divided doses 6, 7

Important Considerations and Contraindications

• Verapamil should only be administered to patients with narrow-complex tachycardias or arrhythmias known with certainty to be of supraventricular origin, according to the American Heart Association 1, 2
• The American College of Cardiology states that verapamil is contraindicated in patients with wide-complex tachycardias, impaired ventricular function or heart failure, left ventricular ejection fraction <40%, and pre-excited atrial fibrillation or flutter 1, 2, 4, 5, 6

Side Effects and Monitoring

• Common adverse effects of verapamil include hypotension, bradycardia, atrioventricular block, and heart failure precipitation, according to the American Heart Association 2, 3, 4, 5
• The European Society of Cardiology recommends monitoring for hemodynamic stability during administration and using verapamil with caution in combination with beta-blockers 1, 2, 4, 5

Clinical Pearls

• The American College of Cardiology recommends verapamil as a Class I recommendation with Level of Evidence B for acute rate control in atrial fibrillation 6, 7
• The European Society of Cardiology suggests that in critically ill patients with severely impaired LV function, intravenous amiodarone may be preferred over verapamil for rate control 4, 5
• The American Heart Association states that verapamil has negative inotropic effects and should be avoided in patients with heart failure 2, 6
• The European Society of Cardiology recommends beta-blockers as first-line therapy for long-term rate control, with calcium channel blockers like verapamil as alternatives 4, 6

Dosage Adjustments

• The American Heart Association recommends considering lower initial doses in elderly patients, patients with hepatic impairment, and patients with renal impairment 1, 4, 5